Most patients aren’t familiar with the term “co-pay accumulator,” or its effect. But they should be, advises a new report from the Alliance for the Adoption of Innovations in Medicine.
Can policymakers prevent new co-pay accumulator programs from surprising patients at the pharmacy counter? The short answer: yes. They have several options, in fact, according to a new overview of policy proposals from the Institute for Patient Access.
“Not everyone can afford the medication they need,” opens a new policy brief from the Institute for Patient Access. Co-pay coupons are one source of financial support for patients. Issued by drug manufacturers, co-pay coupons reduce patients’ out-of-pocket cost. They also help patients meet their annual deductible.
A new trend has more health insurers implementing what are known as co-pay accumulator programs, which change how patients meet their annual deductible. Insurers embrace the programs to increase their revenues and discourage the use of high-cost drugs. But, in so doing, they leave patients with a difficult choice.